Mark Matson
Impact in
- Nephrology top 10%
-
- Lipoproteins and Cardiovascular Health
Papers in
- Oncology 4
- Cytokine Signaling Pathways and Interactions 2
-
- Diabetes Treatment and Management 2
- Neurological and metabolic disorders 2
- Co-authors
- Eric P. Cohen (1 shared paper)Scott M. Wasserman (2 shared papers)Brian P. Smith (2 shared papers)Karen Smirnakis (2 shared papers)John P. Gibbs (3 shared papers)Marc W. Retter (3 shared papers)Bing Gao (3 shared papers)Maurice G. Emery (3 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Antiviral Research (2 papers)Current Medical Research and Opinion (2 papers)The Journal of Clinical Pharmacology (2 papers)Circulation (1 paper)
- Partner nations
- United StatesJapanSweden
In The Last Decade
Mark Matson
27 papers receiving 595 citations
Peers
Comparison fields: 5 of 69
- Nephrology 38
- Surgery 219
- Transplantation 12
- Pulmonary and Respiratory Medicine 106
- Virology 15
Countries citing papers authored by Mark Matson
This map shows the geographic impact of Mark Matson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Matson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Matson more than expected).
Fields of papers citing papers by Mark Matson
This network shows the impact of papers produced by Mark Matson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Matson. The network helps show where Mark Matson may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Matson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 204 | |
| 2 | 1990 | 177 | |
| 3 | 2011 | 40 | |
| 4 | 2011 | 35 | |
| 5 | 1988 | 28 | |
| 6 | 2016 | 24 | |
| 7 | 2019 | 13 | |
| 8 | 2019 | 13 | |
| 9 | 2014 | 12 | |
| 10 | 2014 | 11 | |
| 11 | 2011 | 10 | |
| 12 | 2011 | 9 | |
| 13 | Abstract 10701: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability and Pharmacodynamics of AMG145 | 2011 | 8 |
| 14 | 1988 | 7 | |
| 15 | 1987 | 7 | |
| 16 | 2020 | 5 | |
| 17 | 2019 | 5 | |
| 18 | 2024 | 4 | |
| 19 | 2012 | 3 | |
| 20 | Abstract 19112: A Phase 1, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety/Tolerability, Pharmacokinetic and Hemodynamic Response Following Single Ascending Subcutaneous Doses of PB1046 (Vasomera™) in Subjects with Essential Hypertension | 2014 | 3 |
About Mark Matson
Mark Matson is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism, Infectious Diseases, Pathology and Forensic Medicine and Epidemiology, having authored 27 papers that have together received 627 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (2 papers), Diabetes Treatment and Management (2 papers), Dialysis and Renal Disease Management (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Multiple Sclerosis Research Studies (2 papers), Neurological and metabolic disorders (2 papers) and Neuropeptides and Animal Physiology (2 papers). The work is most often cited by research in Nephrology (38 citations), Surgery (219 citations), Transplantation (12 citations), Pulmonary and Respiratory Medicine (106 citations) and Virology (15 citations). Mark Matson has collaborated with scholars based in United States, Japan and Sweden. Frequent co-authors include Eric P. Cohen, Scott M. Wasserman, Brian P. Smith, Karen Smirnakis, John P. Gibbs, Marc W. Retter, Bing Gao, Maurice G. Emery, Adam J. Shaywitz and Blaire Cooke. Their work appears in journals such as Journal of Clinical Oncology, Antiviral Research, Current Medical Research and Opinion, The Journal of Clinical Pharmacology and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.